FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lavern Vercaigne

Research Profile

Procedures

Devices

Indwelling Catheters

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Lavern M Vercaigne; James Zacharias; Keevin N Bernstein
Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Sheryl A Zelenitsky; Robert E Ariano; Margo L McCrae; Lavern M Vercaigne
Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Ahmed S Abdelmoneim; Sean Armstrong; Dan Chateau; Lisa M Miller; Manish Sood; Lori D Wazny; Lavern M Vercaigne
Use of an alteplase algorithm for the management of hemodialysis catheter dysfunction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lavern Vercaigne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lavern M Vercaigne; James Zacharias; Keevin N Bernstein
Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Clinical nephrology 2012;78(4):287-96.
2012: Sheryl A Zelenitsky; Robert E Ariano; Margo L McCrae; Lavern M Vercaigne
Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(4):527-33.
2012: Ahmed S Abdelmoneim; Sean Armstrong; Dan Chateau; Lisa M Miller; Manish Sood; Lori D Wazny; Lavern M Vercaigne
Use of an alteplase algorithm for the management of hemodialysis catheter dysfunction.
Hemodialysis international. International Symposium on Home Hemodialysis 2012;16(2):298-305.
2010: Dennis Cote; Charmaine E Lok; Marisa Battistella; Lavern M Vercaigne
Stability of trisodium citrate and gentamicin solution for catheter locks after storage in plastic syringes at room temperature.
The Canadian journal of hospital pharmacy 2010;63(4):304-11.
2010: Marisa Battistella; Lavern M Vercaigne; Dennis Cote; Charmaine E Lok
Antibiotic lock: in vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 degrees C.
Hemodialysis international. International Symposium on Home Hemodialysis 2010;14(3):322-6.
2010: Colette B Raymond; Lori D Wazny; Amy R Sood; Lavern M Vercaigne
Establishing and funding renal clinical pharmacy services.
Nephrology news & issues 2010;24(6):40-1, 45-7.
2010: Lavern M Vercaigne; Teresa A Takla; J Raghavan
Long-term effect of an ethanol/sodium citrate locking solution on the mechanical properties of hemodialysis catheters.
The journal of vascular access 2010;11(1):12-6.
2008: Teresa A Takla; Sheryl A Zelenitsky; Lavern M Vercaigne
Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections.
The Journal of antimicrobial chemotherapy 2008;62(5):1024-6.
2008: Anil R Maharaj; Sheryl A Zelenitsky; Lavern M Vercaigne
Effect of an ethanol/trisodium citrate hemodialysis catheter locking solution on isolates of Candida albicans.
Hemodialysis international. International Symposium on Home Hemodialysis 2008;12(3):342-7.
2008: Colette B Raymond; Lori D Wazny; Lavern M Vercaigne; Esther M Lesperance; Dan E Skwarchuk; Keevin N Bernstein
Conversion from epoetin alfa to darbepoetin alfa within the Manitoba Renal Program: evaluation of dose ratios.
CANNT journal = Journal ACITN 2008;18(1):39-43.
2008: Lisa Willms; Lavern M Vercaigne
Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety.
Seminars in dialysis 2008;21(1):71-7.
2007: T A Takla; Sheryl A Zelenitsky; Lavern M Vercaigne
Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections.
The journal of vascular access 2007;8(4):262-7.
2006: Charmaine E Lok; Alison Thomas; Lavern M Vercaigne
A patient-focused approach to thrombolytic use in the management of catheter malfunction.
Seminars in dialysis 2006;19(5):381-90.
2006: A L Bell; R Jayaraman; Lavern M Vercaigne
Effect of ethanol/trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters.
Clinical nephrology 2006;65(5):342-8.
2006: Colette B Raymond; David M Collins; Keevin N Bernstein; Dan E Skwarchuk; Lavern M Vercaigne
Erythropoietin-alpha dosage requirements in a provincial hemodialysis population: effect of switching from subcutaneous to intravenous administration.
Nephron. Clinical practice 2006;102(3-4):c88-92.
2005: Lavern M Vercaigne; David M Collins; S Brian Penner
Conversion from subcutaneous to intravenous erythropoietin in a hemodialysis population.
Journal of clinical pharmacology 2005;45(8):895-900.
2005: George G Zhanel; Christel Johanson; John M Embil; Ayman Noreddin; Alfred Gin; Lavern M Vercaigne; Daryl J Hoban
Ertapenem: review of a new carbapenem.
Expert review of anti-infective therapy 2005;3(1):23-39.
2004: A L Bell; X Gu; Frank J Burczynski; Lavern M Vercaigne
Ethanol/trisodium citrate for hemodialysis catheter lock.
Clinical nephrology 2004;62(5):369-73.
2004: Lavern M Vercaigne; Robert E Ariano; James M Zacharias
Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Clinical pharmacokinetics 2004;43(3):205-10.
2004: George G Zhanel; Kristen Homenuik; Kim Nichol; Ayman Noreddin; Lavern M Vercaigne; John M Embil; Alfred Gin; James A Karlowsky; Daryl J Hoban
The glycylcyclines: a comparative review with the tetracyclines.
Drugs 2004;64(1):63-88.
2003: James M Zacharias; Christine P Weatherston; Candace R Spewak; Lavern M Vercaigne
Alteplase versus urokinase for occluded hemodialysis catheters.
The Annals of pharmacotherapy 2003;37(1):27-33.
2002: Lavern M Vercaigne; Sheryl A Zelenitsky; Ian Findlay; Keevin Bernstein; S Brian Penner
An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters.
The Journal of antimicrobial chemotherapy 2002;49(4):693-6.
2002: George G Zhanel; Michael Walters; Ayman Noreddin; Lavern M Vercaigne; Aleksandra Wierzbowski; John M Embil; Alfred Gin; Stephen Douthwaite; Daryl J Hoban
The ketolides: a critical review.
Drugs 2002;62(12):1771-804.
2002: George G Zhanel; Kelly Ennis; Lavern M Vercaigne; Andrew Walkty; Alfred Gin; John M Embil; Heather Smith; Daryl J Hoban
A critical review of the fluoroquinolones: focus on respiratory infections.
Drugs 2002;62(1):13-59.
2001: George G Zhanel; C Shroeder; Lavern M Vercaigne; John M Embil; A S Gin; D J Hoban
A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins?
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 2001;12(6):379-90.
2001: George G Zhanel; M Dueck; Daryl J Hoban; Lavern M Vercaigne; John M Embil; Alfred Gin; James A Karlowsky
Review of macrolides and ketolides: focus on respiratory tract infections.
Drugs 2001;61(4):443-98.
2000: Lavern M Vercaigne; Daniel S Sitar; S Brian Penner; Keevin Bernstein; G Q Wang; Frank J Burczynski
Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter.
Pharmacotherapy 2000;20(4):394-9.
1999: George G Zhanel; James A Karlowsky; Lorraine Palatnick; Lavern M Vercaigne; Donald E Low; Daryl J Hoban
Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.
Antimicrobial agents and chemotherapy 1999;43(10):2504-9.
1999: George G Zhanel; John M Embil; Alfred Gin; James A Karlowsky; Lavern M Vercaigne; Andrew Walkty; Daryl J Hoban
The new fluoroquinolones: A critical review.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 1999;10(3):207-38.
1998: Lavern M Vercaigne; George G Zhanel
Clinical significance of bioequivalence and interchangeability of narrow therapeutic range drugs: focus on warfarins.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 1998;1(3):92-4.
1998: George G Zhanel; Lionel A Mandell; Andrew E Simor; Lavern M Vercaigne
Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 1998;9(4):215-28.